BCH vs BMA Stock Comparison
BCH currently leads BMA in this stock comparison, with AIQ scores of 55 vs 47. The clearest difference is momentum, while BMA has the stronger value profile.
What is the main difference between BCH and BMA?
BCH leads the current stock comparison as Banco de Chile, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Banco de Chile vs Banco Macro S.A.
BCH leads
BCH leads by 8 AIQ points, primarily on Momentum and Risk Resilience.
Competitive: 4 of 5 evidence groups support BCH, and its current signal state is conflicted.
Banco de Chile
Banco Macro S.A.
The Algovestiq AIQ Score currently favors BCH over BMA, 55 versus 47 as of Nov 15, 2026. BCH's advantage is driven primarily by stronger momentum and risk resilience, while BMA holds the stronger value profile. BCH also shows the stronger technical structure relative to its 50-day moving average. 4 of 5 covered evidence groups favor BCH today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. BCH lead: Stable — the AIQ differential has held near 8 points over 30 sessions.
Compare Banco de Chile and Banco Macro S.A. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BCH and BMA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value9 vs 61BMA +52
- Momentum56 vs 18BCH +38
- Risk Resilience73 vs 49BCH +24
- Quality75 vs 71BCH +4
4 of 5 evidence groups favor BCH. BCH’s edge is concentrated in momentum and risk resilience; BMA keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Momentum -1, not enough on its own to move the overall score.
New signals
- Death Cross Active — bearish, trend, long horizon (0.05%)
- Downtrend Structure Active — bearish, trend, long horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.50x)
Largest factor move: Value -3, not enough on its own to move the overall score.
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-11.2%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
BCH's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — BCH and BMA both carry a full feed there.
The central trade-off
BCH (Banco de Chile): the stronger current systematic profile, led by momentum and risk resilience.
BMA (Banco Macro S.A.): the counter-case, on value, valuation — but at materially higher volatility, 40.4% against 31.7%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BCHBCH on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BMABMA on combined revenue and EPS growth.
Value
BMABMA on the peer-relative Value factor, by 52 points.
Momentum
BCHBCH on the Momentum factor, by 38 points.
Lower downside
BCHBCH on Risk Resilience, by 24 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BCH | BMA | Note |
|---|---|---|---|
| Implied upside to target | — | +60% | Level |
| Target dispersion | — | 0% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 12 | 9 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 5 covered evidence groups favor BCH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | BCH | 55 vs 47 |
| Fundamentals | BCHon balance | revenue growth -25.8% vs -23%; EPS growth -28.3% vs 45.6%; TTM ROE 4.9% vs 3.3%; gross margin 67.4% vs 56.9%; operating margin 36.9% vs 10.5% — BCH takes 3 of 5 decided legs, not all of them |
| Valuation | BMA | Value 9 vs 61 |
| Technicals | BCH | Price vs 50-day -1.4% vs -14.6%; vs 200-day -1.5% vs -27.7% |
| Risk Resilience | BCH | Risk Resilience 73 vs 49 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BCH and BMA and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 8 points.
- 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BCH.
How the comparison changed
120 daily snapshots · May 27 – Nov 13BCH lead: Stable — the AIQ differential has held near 8 points over 30 sessions.
- Today
- BCH +8
- 55 vs 47
- 7 sessions ago
- BCH +6
- 52 vs 46
- 30 sessions ago
- BCH +7
- 52 vs 45
- 90 sessions ago
- BCH +1
- 50 vs 49
The lead changed hands 3 times in this window, most recently on Aug 10 when BCH moved ahead of BMA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 3 bearish / 2 neutral, conflicted
Only BCH
- Bollinger Band Squeeze — neutral, volatility, short horizon (7.6%)
- ADX Trend Weakening — neutral, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.50x)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Midline Reclaim — bullish, momentum, short horizon
2 bullish / 3 bearish / 2 neutral, conflicted
Only BMA
- 52-Week Low Proximity — bearish, risk_regime, long horizon (0.8%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.10%)
- OBV Bullish Divergence — bullish, volume, medium horizon (-11.2%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
Both carry 2 more signals that do not separate them: Death Cross Active, Downtrend Structure Active.
BCH leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.42%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +2.95%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BMA closes the Momentum gap — currently 38 points behind, the largest single contributor to BCH's edge.
- 2BMA's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3BCH's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BCH leads on balance| Metric | BCH | BMA |
|---|---|---|
| Revenue growth (YoY) | -25.8% | -23% |
| EPS growth (YoY) | -28.3% | 45.6% |
| Gross margin | 67.4% | 56.9% |
| Operating margin | 36.9% | 10.5% |
| Return on equity (TTM) | 4.9% | 3.3% |
| Debt to equity | 2.41 | 0.27 |
Performance
BCH leads 6 of 6 windows| Metric | BCH | BMA |
|---|---|---|
| 1 week (5 sessions) | 1.4% | -1.6% |
| 1 month (20 sessions) | 0.7% | -11.2% |
| 3 months (63 sessions) | -4.6% | -27.9% |
| 6 months (126 sessions) | 9.2% | -19.7% |
| Year to date | 3.1% | -36.9% |
| 1 year (252 sessions) | 4.9% | -34.1% |
Technicals
BCH has the stronger structure| Metric | BCH | BMA |
|---|---|---|
| RSI (14) | 51.4 | 35.2 |
| ADX (14) | 14.7 | 34.4 |
| Price vs 50-day | -1.4% | -14.6% |
| Price vs 200-day | -1.5% | -27.7% |
| Volatility (1M, annualized) | 31.7% | 40.4% |
Risk
BCH is the more resilient| Metric | BCH | BMA |
|---|---|---|
| Beta | 1.11 | 1.65 |
| Sharpe ratio | 0.26 | -0.58 |
| Sortino ratio | 0.36 | -0.89 |
| Max drawdown | -24.6% | -47.2% |
| Current drawdown | -15.5% | -45.7% |
| Annualized volatility | 31.7% | 50.6% |
| Value at risk (95%) | -3.1% | -4.6% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BCH or BMA?
On the Algovestiq AIQ Score, BCH is the stronger of the two as of Nov 15, 2026, scoring 55 against BMA's 47. The edge comes from momentum and risk resilience. BMA is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BCH or BMA the better buy right now?
BCH carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor BCH over BMA?
The composite weights Quality, Value, Momentum and Risk Resilience. BMA leads Value by 52 points; BCH leads Momentum by 38 points; BCH leads Risk Resilience by 24 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BCH or BMA?
Analyst price targets imply not covered upside for BCH and +60% for BMA. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BCH or BMA?
BMA is the better-valued of the two on the peer-relative Value factor. BMA on the peer-relative Value factor, by 52 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BCH or BMA?
BMA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BCH or BMA?
BCH on the Momentum factor, by 38 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BCH or BMA?
BCH is the more resilient of the two, so the other name carries the higher downside risk. BCH on Risk Resilience, by 24 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BCH more profitable than BMA?
BCH leads on the comparable margin measures — gross margin 67.4% vs 56.9%; operating margin 36.9% vs 10.5%; ttm roe 4.9% vs 3.3%.
Is BCH's lead over BMA getting stronger or weaker?
BCH lead: Stable — the AIQ differential has held near 8 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-08-10, when BCH moved ahead of BMA.
What would change the BCH vs BMA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BMA closes the Momentum gap — currently 38 points behind, the largest single contributor to BCH's edge; BMA's Death Cross Active resolves — a bearish trend rule currently active against it; BCH's conflicting signal state resolves bearish — it currently carries 2 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about BCH and BMA?
BCH: 2 bullish / 3 bearish / 2 neutral, conflicted. BMA: 2 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BCH is Death Cross Active (bearish, long horizon). On BMA it is Death Cross Active (bearish, long horizon).
Compare BCH and BMA with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.